Rezvilutamide, the Glossary
Rezvilutamide, sold under the brand name Ariane, is a nonsteroidal antiandrogen which is approved for the treatment of prostate cancer in China and is or was under development for the treatment of breast cancer.[1]
Table of Contents
14 relations: Androgen receptor, Apalutamide, Binding selectivity, Brain, Breast cancer, China, Distribution (pharmacology), Enzalutamide, Jiangsu Hengrui, Nonsteroidal antiandrogen, Prostate cancer, Proxalutamide, Receptor antagonist, Structural analog.
- Benzonitriles
- Drugs developed by Jiangsu Hengrui
- Imidazolidines
- Sulfur compounds
Androgen receptor
The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor that is activated by binding any of the androgenic hormones, including testosterone and dihydrotestosterone, in the cytoplasm and then translocating into the nucleus.
See Rezvilutamide and Androgen receptor
Apalutamide
Apalutamide, sold under the brand name Erleada among others, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. Rezvilutamide and Apalutamide are Hormonal antineoplastic drugs, Imidazolidines, nonsteroidal antiandrogens and Trifluoromethyl compounds.
See Rezvilutamide and Apalutamide
Binding selectivity
In chemistry, binding selectivity is defined with respect to the binding of ligands to a substrate forming a complex.
See Rezvilutamide and Binding selectivity
Brain
The brain is an organ that serves as the center of the nervous system in all vertebrate and most invertebrate animals.
Breast cancer
Breast cancer is a cancer that develops from breast tissue.
See Rezvilutamide and Breast cancer
China
China, officially the People's Republic of China (PRC), is a country in East Asia.
Distribution (pharmacology)
Distribution in pharmacology is a branch of pharmacokinetics which describes the reversible transfer of a drug from one location to another within the body.
See Rezvilutamide and Distribution (pharmacology)
Enzalutamide
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. Rezvilutamide and Enzalutamide are Hormonal antineoplastic drugs, Imidazolidines, nonsteroidal antiandrogens and Trifluoromethyl compounds.
See Rezvilutamide and Enzalutamide
Jiangsu Hengrui
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products.
See Rezvilutamide and Jiangsu Hengrui
Nonsteroidal antiandrogen
A nonsteroidal antiandrogen (NSAA) is an antiandrogen with a nonsteroidal chemical structure. Rezvilutamide and nonsteroidal antiandrogen are Hormonal antineoplastic drugs and nonsteroidal antiandrogens.
See Rezvilutamide and Nonsteroidal antiandrogen
Prostate cancer
Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder.
See Rezvilutamide and Prostate cancer
Proxalutamide
Proxalutamide (developmental code name GT-0918) is a nonsteroidal antiandrogen (NSAA) – specifically, a selective high-affinity silent antagonist of the androgen receptor (AR) – which is under development by Suzhou Kintor Pharmaceuticals, inc., a subsidiary of Kintor Pharmaceutical Limited, for the potential treatment of COVID-19, prostate cancer, and breast cancer. Rezvilutamide and Proxalutamide are Hormonal antineoplastic drugs, Imidazolidines, nonsteroidal antiandrogens and Trifluoromethyl compounds.
See Rezvilutamide and Proxalutamide
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
See Rezvilutamide and Receptor antagonist
Structural analog
A structural analog, also known as a chemical analog or simply an analog, is a compound having a structure similar to that of another compound, but differing from it in respect to a certain component.
See Rezvilutamide and Structural analog
See also
Benzonitriles
- 1,4-Dicyanobenzene
- 2,6-Dichlorobenzonitrile
- 2-Chlorobenzonitrile
- 3-Chlorobenzonitrile
- 4-Chlorobenzonitrile
- A-423579
- ABT-239
- Azoxystrobin
- Belzutifan
- Benzonitrile
- Bicalutamide
- Bis(benzonitrile)palladium dichloride
- CBiPES
- Chlorobenzonitrile
- Cimaterol
- Cimoxatone
- Citalopram
- Denifanstat
- Elsulfavirine
- Fotagliptin
- GLPG-0492
- Isophthalonitrile
- LY-320,135
- LY305
- Letrozole
- Ligandrol
- Lolamicin
- Lugduname
- Masofaniten
- Mezigdomide
- Ocedurenone
- Paltusotine
- Phthalonitrile
- RU-59063
- Rezvilutamide
- SB-277,011-A
- Vilazodone
- Vosilasarm
Drugs developed by Jiangsu Hengrui
- Apatinib
- Camrelizumab
- Famitinib
- HRS9531
- Rezvilutamide
- Ruzinurad
- Tegileridine
Imidazolidines
- Apalutamide
- Creatinine
- Enzalutamide
- Hydantoins
- Imidaclothiz
- Imidazolidine
- N-Desmethylenzalutamide
- Proxalutamide
- Pyrilutamide
- RU-59063
- Rezvilutamide
- Simufilam
Sulfur compounds
- Acetylcysteine
- Amidosulfite
- Bis(triethoxysilylpropyl)tetrasulfide
- Carbonaceous sulfur hydride
- Cerium monosulfide
- Dinitrosyl iron complex
- Diphenyl sulfide
- Disulfides
- Ethyl xanthic acid
- FeMoco
- Hydrogen thioperoxide
- Iron–sulfur cluster
- Iron-sulfur protein
- Lanthanum oxysulfide
- Lime sulfur
- ML-154
- Organosulfur compounds
- Osmium tetrasulfide
- Polysulfide
- Polythionates
- Polythionic acid
- Reactive sulfur species
- Rezvilutamide
- Roussin's black salt
- Roussin's red salt
- S-Nitroso-N-acetylpenicillamine
- S-Nitrosothiol
- S-Nitrosotriphenylmethanethiol
- Sulfanyl
- Sulfilimine
- Sulfinyl nitrene
- Sulfur compounds
- Sulfur oxoacid
- Sulfur oxoacids
- Thiocyanates
- Thiokol (polymer)
- Thiosarin
- Thiosulfates
- Thiosulfoxide
- Thiothionyl fluoride
- Trifluorosulfate
- Ytterbium(II) sulfide
- Ytterbium(III) sulfide
References
[1] https://en.wikipedia.org/wiki/Rezvilutamide
Also known as SHR-3680, SHR3680.